CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $475,578 | +53.6% | 14,960 | +17.8% | 0.00% | 0.0% |
| Q1 2023 | $309,680 | -57.4% | 12,697 | -44.9% | 0.00% | -50.0% |
| Q4 2022 | $726,272 | +8.7% | 23,027 | -2.6% | 0.00% | +100.0% |
| Q3 2022 | $668,000 | +127.2% | 23,651 | +112.5% | 0.00% | 0.0% |
| Q2 2022 | $294,000 | -53.8% | 11,131 | -43.2% | 0.00% | 0.0% |
| Q4 2021 | $636,000 | -13.6% | 19,608 | -21.4% | 0.00% | -50.0% |
| Q3 2021 | $736,000 | -5.2% | 24,947 | -17.7% | 0.00% | 0.0% |
| Q2 2021 | $776,000 | – | 30,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |